Literature DB >> 4629259

Antibody responses in serum, colostrum, and milk of swine after infection or vaccination with transmissible gastroenteritis virus.

E H Bohl, R K Gupta, M V Olquin, L J Saif.   

Abstract

The antibody response of pregnant swine to transmissible gastroenteritis (TGE) virus was studied, with special reference to the titers and the immunoglobulin (Ig) class of TGE neutralizing antibodies in colostrum and milk. Animals vaccinated twice intramuscularly or intramammarily with live attenuated TGE virus developed high levels of antibodies in serum and colostrum, but the levels in milk declined markedly within a few days post-farrowing. In contrast, animals naturally or experimentally infected with virulent virus generally developed lower levels of antibodies in serum and colostrum but maintained higher levels in milk, as compared to the vaccinated animals. Gel filtration studies indicated that antibodies in milk from vaccinated animals were primarily of the IgG class, whereas those from the naturally or experimentally infected animals were primarily of the IgA class. The ability of sows to transmit a high degree of passive immunity to their suckling progeny was more closely associated with TGE antibodies of the IgA than the IgG class. Present evidence suggests that high levels of TGE antibodies of the IgA class occur in milk as a result of an infection of the intestinal tract. Probable reasons for this are discussed.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4629259      PMCID: PMC422530          DOI: 10.1128/iai.6.3.289-301.1972

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  24 in total

Review 1.  Secretory immunoglobulins.

Authors:  T B Tomasi; J Bienenstock
Journal:  Adv Immunol       Date:  1968       Impact factor: 3.543

2.  Porcine colostral IgA and IgM antibodies to Escherichia coli and their intestinal absorption by the neonatal piglet.

Authors:  P Porter
Journal:  Immunology       Date:  1969-10       Impact factor: 7.397

3.  Transfer of immunoglobulins IgG, IgA and IgM to lacteal secretions in the parturient sow and their absorption by the neonatal piglet.

Authors:  P Porter
Journal:  Biochim Biophys Acta       Date:  1969-07-01

4.  Secretory gamma-A antibodies induced by local immunization.

Authors:  R J Genco; M A Taubman
Journal:  Nature       Date:  1969-02-15       Impact factor: 49.962

5.  Secretory IgA and antibodies to Escherichia coli in porcine colostrum and milk and their significance in the alimentary tract of the young pig.

Authors:  P Porter; D E Noakes; W D Allen
Journal:  Immunology       Date:  1970-02       Impact factor: 7.397

6.  Some criteria for the field diagnosis of porcine transmissible gastroenteritis.

Authors:  R F Cross; E H Bohl
Journal:  J Am Vet Med Assoc       Date:  1969-02-01       Impact factor: 1.936

7.  Pathogenicity, immunogenicity and distribution of transmissible gastroenteritis virus in pigs.

Authors:  K Harada; S Furuuchi; T Kumagai; J Sasahara
Journal:  Natl Inst Anim Health Q (Tokyo)       Date:  1969

8.  Transmissible gastroenteritis of swine as a model for the study of enteric disease.

Authors:  E O Aelterman; B E Hooper
Journal:  Gastroenterology       Date:  1967-07       Impact factor: 22.682

9.  Morphology of transmissible gastroenteritis virus of pigs. A possible member of coronaviruses. Brief report.

Authors:  M Tajima
Journal:  Arch Gesamte Virusforsch       Date:  1970

10.  Antibodies of the IgA type in intestinal plasma cells of germfree mice after oral or parenteral immunization with ferritin.

Authors:  P A Crabbé; D R Nash; H Bazin; D V Eyssen; J F Heremans
Journal:  J Exp Med       Date:  1969-10-01       Impact factor: 14.307

View more
  83 in total

1.  Protective effect of immunoglobulins in serum and milk of sows exposed to transmissible gastroenteritis virus.

Authors:  M H Abou-Youssef; M Ristic
Journal:  Can J Comp Med       Date:  1975-01

Review 2.  Porcine epidemic diarrhea: a review of current epidemiology and available vaccines.

Authors:  Daesub Song; Hyoungjoon Moon; Bokyu Kang
Journal:  Clin Exp Vaccine Res       Date:  2015-07-29

3.  Transmissible gastroenteritis in Swine in Saskatchewan and some of the difficulties in diagnosing infection due to the virus.

Authors:  S Bauck
Journal:  Can Vet J       Date:  1983-04       Impact factor: 1.008

4.  Development of a nested PCR assay for detection of feline infectious peritonitis virus in clinical specimens.

Authors:  D A Gamble; A Lobbiani; M Gramegna; L E Moore; G Colucci
Journal:  J Clin Microbiol       Date:  1997-03       Impact factor: 5.948

5.  Critical epitopes in transmissible gastroenteritis virus neutralization.

Authors:  G Jiménez; I Correa; M P Melgosa; M J Bullido; L Enjuanes
Journal:  J Virol       Date:  1986-10       Impact factor: 5.103

6.  Tropism of human adenovirus type 5-based vectors in swine and their ability to protect against transmissible gastroenteritis coronavirus.

Authors:  J M Torres; C Alonso; A Ortega; S Mittal; F Graham; L Enjuanes
Journal:  J Virol       Date:  1996-06       Impact factor: 5.103

7.  Passive immunity in transmissible gastroenteritis of swine: immunoglobulin characteristics of antibodies in milk after inoculating virus by different routes.

Authors:  E H Bohl; L J Saif
Journal:  Infect Immun       Date:  1975-01       Impact factor: 3.441

8.  Virus-specific immunity in neonatal and adult mouse rotavirus infection.

Authors:  J F Sheridan; R S Eydelloth; S L Vonderfecht; L Aurelian
Journal:  Infect Immun       Date:  1983-02       Impact factor: 3.441

9.  Monoclonal antibody analysis of neutralization and antibody-dependent enhancement of feline infectious peritonitis virus.

Authors:  W V Corapi; C W Olsen; F W Scott
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

10.  Immunoglobulin classes of antibodies in milk of swine after intranasal exposure to pseudorabies virus or transmissible gastroenteritis virus.

Authors:  L F Saif; E H Bohl
Journal:  Infect Immun       Date:  1977-06       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.